FMP
NASDAQ
2.18 USD
0.02 (0.917%)
Mr. Thomas G. Wiggans
Healthcare
Biotechnology
https://www.pardesbio.com
NASDAQ
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome coronavirus 2 infections and associated diseases. The company was incorporated in 2020 and is headquartered in Carlsbad, California.
0001822711
US69945Q1058
69945Q105
2173 Salk Avenue
415 649 8758
US
57
Dec 27, 2021
0001822711
NASDAQ
Biotechnology
Healthcare
69945Q105
US69945Q1058
US
2.18
0.42
509.69k
135.19M
-
0.75-3.67
0
-
-
-
-
-1.7
-
https://www.pardesbio.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.